ABSTRACT
Cytotoxic T lymphocytes (CTL) eliminate pathogenic cells in large part through the activity of the serine protease granzyme B (grB). However, while the apoptotic activity of grB is blocked by over-expression of Bcl-2, CTL can still kill target cells through an ill-defined Bcl-2-independent pathway. In this report, we have identified key modulators of this Bcl-2-independent cell death pathway which is induced by CTL and not purified components. Surprisingly, activation of this pathway is reliant on grB. Furthermore, this novel pathway requires mitochondrial contribution through triggering of permeability transition and generation of reactive oxygen species, yet is functional in the absence of Bax/Bak. This pathway stimulates movement of target cell mitochondria toward the point of contact with the CTL and importantly, inhibition of this directed movement attenuates killing. Therefore we propose that CTL initiate a target cell response which activates multiple mitochondrial pathways. This ensures that CTL can eliminate those target cells that have compromised apoptotic potential due to over-expression of
Bcl-2.
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INTRODUCTION
One of the major mechanisms used by cytotoxic T lymphocytes (CTL) and natural killers (NK) to destroy pathogenic cells involves directed exocytosis of lytic molecules from the effectors towards the targets [1] [2] [3] [4] [5] . Key proteins, such as perforin, a membrane-disrupting agent and granzymes, a family of serine proteinases, are contained in cytoplasmic granules that polarize toward the contact interface of the immunological synapse 6 . Once perforin is released towards the target cell, it facilitates uptake of the granzymes into the target cell cytoplasm 7 . The proteolytic activities of granzymes result in cleavage of key substrates that activate the dormant cell-death machinery of the cell under attack.
The two major granzymes that have been extensively studied are granzyme A (grA) and granzyme B (grB). The former is a tryptic protease that acts on a number of substrates including Ape1 8 , SET 9 , HMG-2 10 , TREX1 11 and Ku70 12 . GrB is a serine protease with an unusual substrate specificity and cleaves after aspartate residues 13, 14 . One key substrate for grB is the effector caspase, caspase 3 15 . Initially, it was thought that grB acted to induce cell death solely through the activation of caspase 3, however, it then became clear that the situation was more complex 16 .
It was somewhat surprising to discover that the grB pathway was blocked by the antiapoptotic protein Bcl-2. This finding suggested that mitochondria were involved in the mechanism of action of this granzyme. Indeed the loss of mitochondrial membrane potential 17, 18 and cytochrome c release 19, 20 occurred due to grB-mediated cleavage and activation of Bid 21 .
Furthermore, we and others demonstrated that mitochondrial release of Smac/DIABLO 22, 23 was required to relieve Inhibitor of Apoptosis Protein (IAP)-mediated repression of caspase activation 24, 25 . Inhibition of Smac/DIABLO release by increased levels of Bcl-2 protected cells
For personal use only. on October 3, 2017 . by guest www.bloodjournal.org From from grB-induced apoptosis. Therefore, these studies demonstrated the important role of mitochondrial signalling for caspase activation [24] [25] [26] . However, within the context of cell-cell killing, investigations aimed to determine whether Bcl-2 over-expression protects cells from cytotoxic cell-mediated cell death have been less clear, with studies showing both inhibition 27 and lack of effect of Bcl-2 28 . Since grB is one of the major effector molecules of cytotoxic lymphocytes and because we now have a clearer understanding of the mechanism of Bcl-2 inhibition of grB-mediated cell death, we decided to clarify whether cytotoxic lymphocyte-activated cell death was indeed blocked by Bcl-2-overexpression through analysis of multiple apoptotic parameters. More notably, our aim was to elucidate the molecular mechanism of target cell response to CTL-directed attack in the presence or absence of high levels of Bcl-2. Importantly, by evaluating the role of target cell mitochondria in CTL-mediated cell death, these studies have revealed a novel CTL-directed mechanism of mitochondrial-mediated apoptosis initiation within the target cell.
Utilizing both human and mouse target cells that expressed high levels of Bcl-2, we confirmed the study by Sutton et al. 28 that demonstrated target cell death even in the presence of over-expressed Bcl-2. These observations suggested that CTL could either bypass or inactivate Bcl-2 in target cells. Indeed, we show that the Bid/Bax/Bak arm of the pathway is not required.
However, this novel mechanism still appears to involve mitochondria and caspases. Most exciting, we observed that target cell mitochondria aligned along the point of contact with the cytotoxic cell. Inhibition of this directed mitochondrial movement within target cells resulted in diminished CTL-mediated apoptosis. Thus, through mobilization of mitochondria, target cells play an active role in their own demise.
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MATERIALS AND METHODS
Use of mice in this study was approved by the University of Alberta Review Board.
Cell Lines and Reagents. The human T cell lymphoma line Jurkat and transfected J-Bcl-2 cells were maintained as described previously 19 . Human grB was purified from the cytolytic granules of the human NK line YT-Indy (granzyme A-deficient 29 ), as previously described
30
.
The purified grB preparation was assessed by SDS-PAGE silver stain/western blot and displayed one prominent band of expected molecular weight and immunoreactivity for grB, respectively.
Human replication-deficient AD type 5d170-3, was purified from infected 293 cells, as described. Human lymphocytes were prepared as described 31 . C57BL/6; from Dr. W. Clark, University of California, Los Angeles). Splenocytes from these mice were activated in primary mixed lymphocyte cultures using irradiated splenocytes from C3H (H-2 K ) mice (shown in Figure 5 ), or BALB/c (H-2 d ) mice (shown in Figure 6 ) as stimulators for 3 days. CTL and dead stimulator cells were separated by centrifugation through
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Cell death assays. GrB/AD mediated cell death was carried out as described previously 33 .
Briefly, 2 x 10 5 cells/25 ul were treated with indicated amounts of grB and 100 p.f.u. of AD in serum-free media supplemented with 0.1% BSA. For experiments utilizing higher concentrations of grB (as shown in Figure 7B ), grB was initially concentrated 5 fold by centrifugation on Amicon centrifugal filters (Millipore). The cells were incubated for 3 h at 37 o C, before being harvested and assessed for apoptosis. For CTL-mediated apoptosis, CTL and target cells were incubated in the indicated E:T ratios in complete media, before being harvested and assessed for apoptosis.
Apoptosis detection systems. The 3 H-thymidine release assays have been previously Target cell mitochondrial outer membrane permeablization (MOMP) was determined by analysis of loss of staining of Smac/DIABLO through a FACS-based assay 34 . Briefly, target cells were pre-stained with CTFR, as described previously and then incubated with CTL or grB/AD. Cells were resuspended in digitonin buffer (80mM KCl, 50ng/ml digitonin, 1mM EDTA in PBS), which would cause loss of cytosolic proteins, and then processed for intracellular staining of Smac/DIABLO or the control COXIV, followed by analysis by flow cytometry.
Microscopy. with effector CTLs at increasing effector to target ratios (E:T) and apoptotic features of the target cell were analyzed (Figure 1 ). Target cell death was also initiated by incubation with purified grB and replication deficient adenovirus (AD). AD is a well characterized functional substitute for the granular pore-forming protein perforin, inducing endosomal disruption to facilitate the delivery of grB into the cytosol of the target cell 35 . Figure 1A Therefore, while increased levels of Bcl-2 can protect cells from apoptosis initiated by purified grB/AD treatment, these same levels of Bcl-2 do not completely protect cells from CTLmediated apoptosis.
Nevertheless, while CTL-mediated cell death is diminished in these Bcl-2-overexpressing cells, these cells are not completely protected from CTL-mediated apoptosis. In fact, a significant proportion of these target cells still die (50%-80%). Therefore, CTL employ 2 distinct pathways when activating cell death in target cells that express high levels of Bcl-2. One pathway is inhibited by Bcl-2 and the other is independent of Bcl-2. Certainly, grB activated apoptotic mechanisms contribute to cell death in the Bcl-2-dependent apoptotic pathway. However, the signalling pathways which trigger the Bcl-2-independent CTL-mediated apoptotic pathways are completely unknown. Therefore, we resolved to characterize and decipher the molecular mechanisms of CTL-directed, Bcl-2-independent cell death.
The CTL-activated Bcl-2-independent pathway activates the mitochondrial apoptotic pathway. Bcl-2 is mainly localized to the mitochondrion and inhibits mitochondrial dysfunction initiated by various apoptotic stimuli 36 . We wished to determine whether mitochondria were involved in the CTL-mediated Bcl-2-independent death pathway. First we assessed mitochondrial dysfunction by analysis of electrochemical potential in Bcl-2 over-expressing targets that had been treated with CTL. Non-apoptotic cells with healthy, respiring mitochondria
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From will be fluorescent when incubated with the potentiometric dye TMRE. As cells activate the mitochondrial apoptotic program and lose the electrochemical potential (∆ψ) across the inner membrane, red fluorescence will diminish. As can be seen in Figure 2 We also assessed mitochondrial dysfunction by determining the amount of mitochondrial outer membrane permeabilization (MOMP), via release of the mitochondrial pro-apoptotic protein Smac/DIABLO 22, 23 . As can be seen in Figure 2C , target cells treated with either CTL, or grB/AD displayed a robust loss of Smac/DIABLO staining (33% or 22% respectively). However, a significant difference was seen in the Bcl-2 transfected cells. While Smac/DIABLO release was completely inhibited in response to grB/AD, CTL treatment still liberated Smac/DIABLO to the cytosol. Smac/DIABLO release was due to MOMP and not due to non-specific destruction of mitochondria, as there was little loss of staining of the control integral membrane protein, COXIV ( Figure 2C, right) . Thus, although Bcl-2 can block mitochondrial dysfunction when cells are treated with purified grB as the apoptotic initiator, in the presence of whole CTL, proapoptotic protein Smac/DIABLO is still released from the mitochondria and presumably facilitates the activation of caspases. Therefore, target cells incubated with CTL activate mitochondrial apoptotic pathway even in the presence of Bcl-2.
The Bcl-2-independent cell death pathway is also independent of Bax/Bak and Bid. We sought to investigate the mechanism whereby CTL activate the mitochondrial apoptotic pathway in the presence of overexpression of Bcl-2. It is possible that CTL trigger a pathway that results in the direct inactivation of Bcl-2 and thus cells overexpressing Bcl-2 would not be protected against cell death (as is the case here). However, cells that harbour perturbations in the pathway to mitochondrial dysfunction that occur upstream or downstream of Bcl-2 action should be resistant to CTL-mediated apoptosis. We tested this hypothesis with target cells that lack the apoptotic activating molecules Bid and Bax/Bak, and assessed their sensitivity to CTL-mediated killing. Two readouts of apoptosis were monitored: caspase activation and DNA fragmentation.
As seen in Figure 3 , significant levels of both caspase activation and DNA fragmentation occurred when the Bid or Bax/Bak KO cells were used as targets for CTL. Therefore, CTL can kill targets that not only over-express the anti-apoptotic protein Bcl-2, but can also kill cells that lack the ability to activate MOMP through the well characterized Bid/Bax/Bak pathway. This suggests that CTL do not overcome Bcl-2 protection simply by inhibiting Bcl-2 function, but may subvert the requirement for formation of Bax/Bak pores to facilitate Smac/DIABLO release and subsequent caspase activation and DNA damage.
Mitochondria are involved in the CTL-mediated Bcl-2-independent cell death pathway.
An alternative mechanism that causes the release of pro-apoptotic molecules from the mitochondria is characterized by the sustained opening of the mitochondrial permeability transition pore (PTP). Therefore, we tested whether the opening of the PTP was a required step in CTL-mediated apoptosis. Cyclosporine A (CsA) is a potent inhibitor of the PTP 37 and has been used to test the involvement of the PTP in apoptosis [38] [39] [40] [41] . To control for loading conditions in experiments where CsA was used 42 , we simultaneously treated the cells with verapamil 43 , which is an inhibitor of the plasma membrane drug resistance pump 44 , but not an inhibitor of PTP 45 . We have previously shown that CsA does not inhibit grB/AD-mediated death 18 . In contrast, CsA treatment repressed CTL-mediated killing of Jneo cells ( Figure 4A ). This CsA-dependent protection was also evident in JBcl-2 cells suggesting that activation of the PTP is a requirement for both the Bcl-2-dependent and -independent pathways. Furthermore, these results demonstrate that the activation of the mitochondrial pathway as initiated by CTL is not merely a consequence of the cell dying, but is required for execution of apoptosis. Therefore, although purified grB activate apoptosis independent of PTP opening, CTL can also trigger target cell death through a pathway that requires PTP signalling. death. This hypothesis was tested in Figure 4B . Target cells over-expressing Bcl-2 were incubated with CTL in the presence and absence of the ROS scavenger, D1417. Figure 4B demonstrated that sequestration of ROS caused a marked reduction in CTL-mediated cell death as assessed by tritium release. In contrast, grB/AD-mediated cell death was less reliant on ROS production. This result in addition to the requirement for the PTP demonstrated that mitochondria were indeed required for the execution of the CTL-mediated Bcl-2-independent apoptotic pathway.
CTL-mediated Bcl-2-independent pathway is dependent on grB. Purified grB delivered
into the target cell cytoplasm is not capable of activating a Bcl-2-independent cell death program ( Figure 1 ). Granzyme A, on the other hand, can activate mitochondrial damage through a Bcl-2-independent cell death pathway, although grA-mediated cell death cannot be detected by tritium
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. However, tritium release and caspase activation are the parameters that are activated in the observed CTL-dependent, Bcl-2-independent pathway described here. Thus it appeared unlikely that grA would contribute to the apoptotic changes we observed in the Bcl2-independent pathway, although we decided to specifically address the role of grA by using grA-deficient CTL. CTL derived from mice carrying targeted deletions of grA and grB were isolated and their ability to initiate apoptosis in target cells over-expressing Bcl-2 were assessed ( Figure 5 ). Mouse target cells (L cells) were generated that over-expressed Bcl-2.
Similar to the Jurkat cells that over-expressed Bcl-2 (JBcl-2), the mouse L cells that were transfected with Bcl-2 (LBcl-2) did not display caspase activation and tritium release when incubated with purified grB/AD, but were still killed by incubation with WT CTL ( Figure 5 ).
Furthermore, grA null CTL also initiated caspase activation and tritium release in Bcl-2-overexpressing targets. In contrast, grB null CTL showed reduced caspase activation and near complete loss of tritium release in both control and Bcl-2-overexpressing targets. Thus, grB and not grA was required for the execution of the Bcl-2-dependent and -independent cell death pathway. The important result is that the CTL can overcome the Bcl-2 block in the absence of grA. Therefore, this Bcl-2-independent killing is dependent on grB, probably in conjunction with other unknown factors.
Target cell mitochondria migrate to point of contact between effector cell and target cell.
The observation that grB is required for the Bcl-2-independent pathway raised the question of why purified grB could not activate the Bcl-2-independent pathway. Possibly once released into the target cell cytoplasm, grB cooperates with another CTL-delivered molecule to induce target cell apoptosis despite increased levels of Bcl-2. Alternatively, grB could cooperate with another signalling pathway which has been activated by CTL, possibly through CTL-target cell contact. 
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Clearly, CTL interaction with target cells activates a number of signalling pathways which are not triggered by purified grB alone.
We decided to address the question of whether the Bcl-2-independent pathway was triggered by signalling pathways that were activated upon CTL-target cell contact. Knowing that CTL activate the mitochondrial apoptotic program within the target cell, we observed the target cell mitochondria of human CTL-target cell conjugates using microscopy. Human Jurkat target cells and human CTL were mixed and examined by immunofluorescence using anti-CD8 to identify the CTL and anti-cytochrome c antibodies to determine the localization of mitochondria.
Analysis of conjugates was done within 5 minutes of cell mixing so that mitochondrial release of cytochrome c had not yet occurred. Conjugates between CTL and target cells (one CTL in contact with one target cell) were identified. We observed that unconjugated target cells and 75% of the target cells that were conjugated with CTL, had mitochondrial localization that was distributed throughout the cytoplasm as shown in Figure 6Ai . However in 25% of conjugates, the target cells displayed a mitochondrial distribution, which was polarized toward the effector cell (Figure 6Aii-iv) . To determine whether mitochondrial polarization also occurred in mouse cell conjugates, we repeated conjugate analyses with mouse CTL incubated with mouse L1210 targets. We pre-labelled L1210 target cells with Mitotracker Red and repeated conjugate experiments as described, identifying CTL with anti-CD8. We observed similar mitochondrial polarization in 54% of mouse target cell conjugates (Figure 6Av-vii) . Thus mitochondria from both human and mouse target cells were clustered at the point of contact between the two cells and were more closely aligned towards the membranes near the predicted immunological synapse. This suggested that upon contact with CTL, the mitochondria within the target cell are transported toward the CTL. 
Importantly, this polarized mobilization of intracellular organelles to the point of contact between target and effector cells has been observed for target cell lysosomes and endosomes 7 .
This organeller movement is triggered by damaged membranes that cause a rapid rise in intracellular Ca 2+ concentrations and cause endomembranes to mobilize to the site of damage and reseal the damaged plasma membrane 48 . CTL-mediated lysosomal movement was required to repair membrane damage that was caused by perforin, and allow the target cell time to initiate the apoptotic program and avoid death by necrosis. We wanted to determine if this same mechanism for movement of endomembranes caused mitochondrial mobilization, so we assessed whether mitochondrial movement was ablated in conjugates formed between target cells and CTL which were deficient for perforin. We observed that mitochondrial polarization occurred not only due to interaction with WT CTL, but also due to interaction with PerKO CTL and grB KO CTL ( Figure 6B ). Therefore, the mitochondrial movement is activated by another, as yet unknown, mechanism.
A critical prediction from these results is that the movement of mitochondria to the synapse would be required for killing. We tested whether this migration would have functional relevance to the CTL-mediated apoptotic pathway. In higher eukaryotes, mitochondria migrate via microtubules 49 . We disrupted the microtubular network with colchicine and determined whether this affected the CTL-mediated Bcl-2-independent pathway ( Figure 7A ). Colchicine treatment of cells alone did not induce mitochondrial depolarization or ROS production (not shown). In the presence of colchicine, there was repression of cell death of Jneo cells and importantly, a stronger repression of cell death in JBcl-2 cells. To ensure that these effects were not due to a non-microtubule-dependent effect from colchicine treatment, we repeated the experiments with both the microtubule disrupting drug colchicine and the microtubule-stabilizing
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demonstrates that both drugs inhibited the Bcl2-independent apoptotic pathway. This suggests that execution of CTL-mediated cell death requires functional microtubules. Specifically, since the Bcl-2-independent pathway displayed a greater sensitivity to microtubule disruption, these results support our hypothesis that mitochondrial migration toward the immunological synapse is a necessary step towards CTL-mediated apoptosis of Bcl-2-expressing cells.
One possible mechanism of activation of the Bcl2-independent pathway is that CTL deliver a highly concentrated pulse of grB within an area of the target cell that has increased concentration of the target organelles, mitochondria. If this is true, then it may be possible to activate the Bcl2-independent pathway by in vitro delivery of very high doses of grB. To test this hypothesis, we incubated Bcl2-expressing cells with higher doses of grB (nearly 200 fold over the standard conditions) and assessed cell death ( Figure 7B) . Indeed, addition of high levels of grB (compare 30nM to 1.3 µM or 5.9 µM) did result in activation of mitochondrial dysfunction and caspase activation in Bcl-2-expressing cells. This suggests that CTL delivery of high local concentrations of grB in the vicinity of aggregated mitochondria, may induce cell death independent of elevated levels of Bcl-2.
DISCUSSION
Extensive investigations have demonstrated that grB cannot kill Bcl-2 over-expressing cells but the situation with CTL was unclear. We show that CTL activate a Bcl-2-independent apoptotic pathway, which is characterized by caspase activation, double-strand DNA damage and mitochondrial loss of ∆ψ and Smac/DIABLO. This pathway is independent of grA, Bid/Bax/Bak but is dependent on activation of the mitochondrial permeability transition. . By analyzing apoptotic features that are not induced by grA ( 3 H-release assays and caspase activation), and by utilizing CTL which were derived from grA knock-out mice, we have identified a grA-independent cell death pathway that contributes to the elimination of target cells over-expressing Bcl-2. Therefore, although grA contributes to the CTL-mediated cell death of Bcl-2-expressing target cells, we have focused on grA-independent apoptotic features in order to dissect the mechanisms of caspase activation and DNA double strand breaks that are induced by CTL even in the presence of high levels of Bcl-2.
In this report, we show that grB plays a major role in this CTL-mediated, Bcl-2-independent cell death pathway since CTL lacking grB did not induce DNA damage in either control target cells or targets with elevated levels of Bcl-2. This was surprising, because initial in vitro studies using purified grB demonstrated that grB only activates a Bcl-2-dependent mitochondrial apoptotic pathway 24, 25, 28 . However, Thomas et al. 42 have provided evidence for a grB-pathway that is independent of the Bcl-2 family members Bid, Bax and Bak 42 , although in those in vitro experiments quite high concentrations of grB (1 µM) were used. We routinely perform our killing assays with relatively low amounts of grB (2.5 to 90 nM), and at these concentrations, Bcl-2 is an effective block. Taken together, one possible implication from these
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As we discuss later, the delivery of a concentrated pulse of grB may be quite relevant to our model of CTL-mediated killing.
Although CTL induce a Bid-Bax/Bak-independent killing pathway, mitochondrial events Therefore, MOMP and ∆ψ loss of the Bcl-2-independent CTL-mediated apoptotic program is triggered both through a Bid-Bax/Bak-dependent mechanism and through another separate pathway.
In support of the presence of an alternative mitochondrial activation pathway, it has been shown in the mouse system that the Bid pathway is not directly involved in mitochondrial dysfunction 53 . Recently it has also been demonstrated that human and mouse grB exhibit different abilities to cleave other substrates in addition to Bid 54 . These differences are undoubtedly important in the mechanisms used by mice and human CTL and illustrate the dangers of crossing species. They also offer an explanation for the discrepancies in the literature regarding the importance of Bid 42, 55 . The lack of a "Bid-amplification arm" also contributes to the low cytotoxicity of mouse grB relative to human 56 . However, despite the differences in the in vitro potency of grB, CTL from mice and humans have quite similar cytolytic and apoptotic activities at equal effector to target ratios. It is intriguing to speculate that the mechanism described in the present work, which was revealed in human targets transfected with Bcl-2, may be the major pathway used by the mouse. The localized delivery of a highly concentrated pulse of grB by CTL may be the physiologically relevant context that is mimicked by the need to use large doses of mouse grB on target cells in vitro 42, 56 .
Activation of the mitochondrial permeability transition pore (PTP) can also induce MOMP and loss of ∆ψ. Independent of the Bid-Bax/Bak pathway, apoptotic stimuli induce mitochondrial permeability through opening of inner mitochondrial membrane pores that cause osmotic swelling of the mitochondrial matrix, rupture of the outer mitochondrial membrane and release of mitochondrial inter-membrane space proteins 57, 58 . We determined whether the PTP was induced in target cells treated with CTL by analyzing cell death in the presence of the PTPinhibitor CsA. Inhibition of PTP decreased the levels of apoptosis in target cells ( Figure 4A) demonstrating that PTP opening facilitated CTL-mediated cell death and importantly, that the activation of the mitochondrial apoptotic pathway was a functional requirement for apoptosis induction of Bcl-2-overexpressing cells and not merely a consequence of the activation of cell death signalling pathways. Furthermore, in the healthy cellular state, mitochondrial production of the ROS superoxide (O 2 -) is countered by an antioxidant defence mechanism. Under apoptotic conditions, mitochondrial damage causes a net increase in ROS which in turn can further damage mitochondria, thereby contributing to the progression of the cellular apoptotic pathway 59 . ROS production is a required step for activation of both grA-and grB-mediated cell death 47 . We showed that ROS production was required for CTL-mediated cell death in Bcl-2-expressing
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Given that the mitochondria played a critical role in the grB-dependent, Bcl-2-independent apoptotic pathway, we were puzzled as to why this pathway was activated by CTL and not by treatment with purified grB. We observed that CTL:target cell conjugates showed an accumulation of mitochondria at the target face of the immunological synapse ( Figure 6 ). In support of direct activation of grB on the mitochondrial apoptotic pathway, MacDonald et al. 17 had shown that grB can induce mitochondrial dysfunction of isolated mitochondria. Possibly accumulation of target cell mitochondria at sites of high local intracellular concentrations of grB facilitate direct activation of the mitochondrial apoptotic pathway independent of Bcl-2. In support of the idea that high concentrations of grB can
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Therefore we suggest a model whereby contact with CTL signals target cell mobilization of mitochondria to the point of contact. The accumulation of mitochondria in the region where grB enters the cell, and may be an area of high local grB concentration, could set the stage for the activation of the (Bid-Bax/Bak)/Bcl-2-independent killing pathway. Therefore, this mitochondrial polarization may provide a means to overcome Bcl-2 protection in target cells. By facilitating this alternative mitochondrial apoptotic pathway, the target cell plays an active role in its own demise. This has long-ranging implications in the treatment of cancer given Bcl-2 is over-expressed in a broad range of malignancies 62 . As a result, identifying the molecular mechanisms of cytotoxic T cell-mediated apoptosis may make it possible to enhance the immune system's ability to eliminate tumours. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
